middle.news
How Racura’s G4-DNA Discovery Could Revolutionise Cancer Treatment
9:26am on Thursday 29th of January, 2026 AEDT
•
Healthcare
Read Story
How Racura’s G4-DNA Discovery Could Revolutionise Cancer Treatment
9:26am on Thursday 29th of January, 2026 AEDT
Key Points
Discovery that (E,E)-bisantrene targets G4-DNA & RNA structures, not doxorubicin-like action
Filing of composition of matter patent claims securing 20 years protection
Expanded clinical programs in EGFR mutant lung cancer and acute myeloid leukaemia
Private placement raised $3.22 million at a premium, plus $5.62 million from option conversions
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
RAC
OPEN ARTICLE